Literature DB >> 32815876

NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML.

Astrid Behnert1,2, Alex G Lee1,2, Elizabeth P Young1, Marcus R Breese1,2, Stanley G Leung1,2, Inge Behroozfard1, Maria Maruffi3, E Alejandro Sweet-Cordero1,2, Christopher C Dvorak1,2, Julia Chu1, Elliot Stieglitz1,2.   

Abstract

Overlapping myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are clonal hematopoietic disorders with features of myelodysplasia and myeloproliferation. The only well-characterized MDS/MPN in children is juvenile myelomonocytic leukemia, an aggressive disorder of infants and toddlers. The biochemical hallmark of this disease is hyperactivation of the Ras/MAPK signaling pathway caused by mutations in Ras pathway genes in more than 90% of patients. Translocations involving receptor tyrosine kinases have been identified in rare cases. Here, we report a 2-year-old patient who presented with MDS/MPN driven by a cytogenetically cryptic NUP98-NSD1 fusion, a translocation thought to exclusively occur in patients with acute myeloid leukemia.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32815876      PMCID: PMC7889745          DOI: 10.1097/MPH.0000000000001913

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  19 in total

1.  Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations.

Authors:  V-P Lavallée; S Lemieux; G Boucher; P Gendron; I Boivin; S Girard; J Hébert; G Sauvageau
Journal:  Leukemia       Date:  2016-02-09       Impact factor: 11.528

2.  Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.

Authors:  Angeliki Thanasopoulou; Alexandar Tzankov; Juerg Schwaller
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

3.  Integrated molecular profiling of juvenile myelomonocytic leukemia.

Authors:  Norihiro Murakami; Yusuke Okuno; Kenichi Yoshida; Yuichi Shiraishi; Genta Nagae; Kyogo Suzuki; Atsushi Narita; Hirotoshi Sakaguchi; Nozomu Kawashima; Xinan Wang; Yinyan Xu; Kenichi Chiba; Hiroko Tanaka; Asahito Hama; Masashi Sanada; Masafumi Ito; Masashi Hirayama; Arata Watanabe; Toshihide Ueno; Seiji Kojima; Hiroyuki Aburatani; Hiroyuki Mano; Satoru Miyano; Seishi Ogawa; Yoshiyuki Takahashi; Hideki Muramatsu
Journal:  Blood       Date:  2018-02-02       Impact factor: 22.113

Review 4.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

5.  High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.

Authors:  Anna Candoni; Federico De Marchi; Maria Elena Zannier; Davide Lazzarotto; Carla Filì; Maria Vittoria Dubbini; Nicholas Rabassi; Eleonora Toffoletti; Bonnie W Lau; Renato Fanin
Journal:  Leuk Res       Date:  2017-10-27       Impact factor: 3.156

6.  Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Authors:  Elliot Stieglitz; Ashley F Ward; Robert B Gerbing; Todd A Alonzo; Robert J Arceci; Y Lucy Liu; Peter D Emanuel; Brigitte C Widemann; Jennifer W Cheng; Nalini Jayaprakash; Frank M Balis; Robert P Castleberry; Nancy J Bunin; Mignon L Loh; Todd M Cooper
Journal:  Pediatr Blood Cancer       Date:  2014-12-08       Impact factor: 3.167

Review 7.  Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.

Authors:  Tiffany Y Chang; Christopher C Dvorak; Mignon L Loh
Journal:  Blood       Date:  2014-08-27       Impact factor: 22.113

8.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

9.  Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion.

Authors:  Yoko Mizoguchi; Naoto Fujita; Tomohiko Taki; Yasuhide Hayashi; Kazuko Hamamoto
Journal:  Am J Hematol       Date:  2009-05       Impact factor: 10.047

10.  Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.

Authors:  Joseph A Clara; David A Sallman; Eric Padron
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

View more
  1 in total

1.  Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.

Authors:  Astrid Wintering; Christopher C Dvorak; Elliot Stieglitz; Mignon L Loh
Journal:  Blood Adv       Date:  2021-11-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.